FDA Drug Safety Communication issued regarding an increased risk of fractures of the hip, wrist and spine associated with PPI use.
2010 – FDA Drug Safety Communication issued
Announcement Date: May 25, 2010
FDA Drug Safety Communication issued regarding an increased risk of fractures of the hip, wrist and spine associated with PPI use.